How Psilocybin Works in the Brain: Neuroscience Explained
About This Video
Andrew Huberman breaks down the neuropharmacology of psilocybin in characteristically rigorous fashion — this is one of the clearest lay-audience explanations of the 5-HT2A receptor agonism mechanism and what it actually means for subjective experience. The key insight is that psilocybin doesn't flood the brain with serotonin; it mimics serotonin at specific receptor subtypes, particularly those densely expressed in the prefrontal cortex and default mode network.
The default mode network (DMN) section is the most valuable part of the video. The DMN is the brain's self-referential network — the voice in your head, your sense of being a separate self. High-dose psilocybin dramatically reduces DMN activity, which correlates with the dissolution of ego boundaries and the loss of ordinary self-referential thinking. This disruption appears to be what makes therapeutic breakthroughs possible: deeply ingrained thought patterns, maintained by the DMN's default activity, temporarily lose their grip.
Key Takeaways
- Psilocybin is a 5-HT2A receptor agonist — it mimics serotonin at specific subtypes, it does not flood the brain with serotonin.
- The default mode network (DMN) governs self-referential thought; psilocybin suppresses DMN activity, reducing ego-bound thinking.
- Neuroplasticity is measurably increased in the 2–4 weeks following a psilocybin session — this is the window when integration work has maximum effect.
- Functional connectivity between brain regions that don't normally communicate increases acutely, which may explain cross-modal experiences and novel insights.
- The 5-HT2A mechanism also explains why SSRIs blunt psilocybin effects — chronic SSRI use downregulates 5-HT2A receptor density.
Dive Deeper
Continue exploring this topic on LearnShrooms: